Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population

Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population

Abstract Background The methylation SEPT9 (mSEPT9) appeared to be effective for hepatocellular carcinoma (HCC) detection. However, its performance in high-risk population has not been validated. We designed a pilot study and aimed to investigate the performance of mSEPT9, AFP, PIVKA-II and their com...

Full description

Bibliographic Details
Main Authors: Kepu Zheng, Leiyang Dai, Yingpeng Zhao, Laibang Li, Wang Li, Xibing Zhang, Qiuming Su, Ruichao Wu, Yizhou Jiang, Yonglin Chen, Jianghua Ran
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Gastroenterology
Subjects:
SEPT9
Septin9
Hepatocellular carcinoma
HCC
Screening
Hepatic cirrhosis
Online Access:https://doi.org/10.1186/s12876-023-02900-6

Internet

https://doi.org/10.1186/s12876-023-02900-6

Similar Items